During the past decade, Kyoto University Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kyoto University Hospital" are "Advanced Solid Tumors or Triple-negative Breast Cancer" (1 trials) and "Ankylosing Spondylitis" (1 trials). Many other conditions were trialed in "Kyoto University Hospital" in a lesser frequency.

Most popular intervention types in "Kyoto University Hospital" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sacituzumab Govitecan-hziy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kyoto University Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kyoto University Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kyoto University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kyoto University Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".